COMPARE · Reviewed August 3, 2026

FTV vs ITRI

Verdict: Side-by-side breakdown using the Bull Rankings model. FTV scored 57.7, ITRI scored 58.7 — ITRI leads.
Compare another set
FTV
Fortive Corporation
Scientific & Technical Instruments · Quality-Growth
57.7
$59.46 · $18.0B
fundamentals as of
Score gap
1.0
ITRI leads
ITRI
Itron, Inc.
Scientific & Technical Instruments · Quality-Growth
58.7
$100.95 · $4.4B
fundamentals as of
THE BULL RANKINGS SCORECARD58/ 100 · BULL SCOREPEER MEDIANQUALITY63GROWTH56VALUE55
THE BULL RANKINGS SCORECARD59/ 100 · BULL SCOREPEER MEDIANQUALITY65GROWTH41VALUE76
FTV
stronger →← stronger
ITRI
63
Qualityreturns · margins · balance sheet
65
56
Growthrevenue & earnings expansion
41
55
Valuevaluation vs sector peers
76
ITRI is stronger on 2 of 3 pillars.
FTV
ITRI
$966mC+
FCF
$385mC
+3.6%C+
Rev
-5.7%D
0.59C+
D/E
0.98C
31.5xB
P/E
16.9xA-
0.98B+
PEG
0.88B+
Winner per row is the stronger grade in our model; a tie or a missing value shows no highlight.
FTV
ITRI
12% above
Price vs fair valuelower is cheaper
9% below
~8%/yr
Growth the price implies10-yr FCF · lower = less priced in
~3%/yr
-16%
1-yr DCF upside
+5%
-10%
5-yr DCF upside
+10%
-2%
10-yr DCF upside
+17%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
FTV
Why this score
  • Buying back stock
ITRI
Why this score
  • Buying back stock
FTVFortive Corporation
Scientific & Technical Instruments · $59.46 · beta 0.98
Why now
Scientific & Technical Instruments · market cap $18.0b. 8% off the 52-week high of $64.56. PEG 0.98 — paying under fair value for the growth rate. 13 sell-side analysts rate this a Hold with a mean 1-yr target of $64.31 (implying +8% upside).
Moat
FCF converts 194% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Trailing P/E 31x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates.
ITRIItron, Inc.
Scientific & Technical Instruments · $100.95 · beta 1.33
Why now
Scientific & Technical Instruments · market cap $4.4b. Down 29% from 52-week high of $142.00 — deep drawdown territory. Revenue -6% — in contraction; any catalyst that reverses this triggers re-rating. PEG 0.88 — paying under fair value for the growth rate. 10 sell-side analysts rate this a Buy with a mean 1-yr target of $129.60 (implying +28% upside).
Moat
ROE 17% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately. FCF converts 141% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Revenue contracting -6% — the operational turn is not yet visible in the top line.
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.